Literature DB >> 11278300

Identification of human macrophage inflammatory proteins 1alpha and 1beta as a native secreted heterodimer.

E Guan1, J Wang, M A Norcross.   

Abstract

Chemokines are secreted proteins that function as chemoattractants for leukocytes. The chemokines macrophage inflammatory protein 1alpha and 1beta (MIP-1alpha and MIP-1beta) now have been shown to be secreted from activated human monocytes and peripheral blood lymphocytes (PBLs) as a heterodimer. Immunoprecipitation and immunoblot analysis revealed that antibodies to either MIP-1alpha or MIP-1beta precipitated a protein complex containing both MIP-1alpha and MIP-1beta under normal conditions from culture supernatants and lysates of these cells. Mass spectrometry of the complexes, precipitated from the culture supernatants of monocytes and PBLs, revealed the presence of NH(2)-terminal truncated MIP-1alpha (residues 5-70) together with either intact MIP-1beta or NH(2)-terminal truncated MIP-1beta (residues 3-69), respectively. The secreted MIP-1alpha/beta heterodimers were dissociated into their component monomers under acidic conditions. Exposure of monocytes or PBLs to monensin induced the accumulation of heterodimers composed of NH(2)-terminal truncated MIP-1alpha and full-length MIP-1beta in the Golgi complex. The mixing of recombinant chemokines in vitro demonstrated that heterodimerization of MIP-1alpha and MIP-1beta is specific and that it occurs at physiological conditions, pH 7.4, and in the range of nanomolar concentrations. The data presented here provide the first biochemical evidence for the existence of chemokine heterodimers under natural conditions. Formation of heterodimers of MIP-1alpha/beta may have an impact on intracellular signaling events that contribute to CCR5 and possibly to other chemokine receptor functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278300     DOI: 10.1074/jbc.M006327200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Temporal phenotypic features distinguish polarized macrophages in vitro.

Authors:  David W Melton; Linda M McManus; Jonathan A L Gelfond; Paula K Shireman
Journal:  Autoimmunity       Date:  2015-03-31       Impact factor: 2.815

2.  Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditions.

Authors:  E Sonay Kuloğlu; Darrell R McCaslin; John L Markley; Brian F Volkman
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

3.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

Review 4.  Therapeutic targeting of chemokine interactions in atherosclerosis.

Authors:  Rory R Koenen; Christian Weber
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

Review 5.  Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease.

Authors:  R Colobran; E Pedrosa; L Carretero-Iglesia; M Juan
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

6.  T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.

Authors:  Scott J Patterson; Anne M Pesenacker; Adele Y Wang; Jana Gillies; Majid Mojibian; Kim Morishita; Rusung Tan; Timothy J Kieffer; C Bruce Verchere; Constadina Panagiotopoulos; Megan K Levings
Journal:  J Clin Invest       Date:  2016-02-08       Impact factor: 14.808

7.  Early Brain Injury Associated with Systemic Inflammation After Subarachnoid Hemorrhage.

Authors:  Jude Savarraj; Kaushik Parsha; Georgene Hergenroeder; Sungho Ahn; Tiffany R Chang; Dong H Kim; H Alex Choi
Journal:  Neurocrit Care       Date:  2018-04       Impact factor: 3.210

8.  Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients.

Authors:  E-M Reitter; C Ay; A Kaider; R Pirker; C Zielinski; G Zlabinger; I Pabinger
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

9.  Gene expression analysis for pneumonia caused by Gram-positive bacterial infection.

Authors:  Rufu Jia; Jingyan Yang; Ying Cui; Dongjie Guo; Tiejun Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

Review 10.  Applications of chemokines as adjuvants for vaccine immunotherapy.

Authors:  Teena Mohan; Wandi Zhu; Ye Wang; Bao-Zhong Wang
Journal:  Immunobiology       Date:  2017-12-08       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.